文献速递胸部病理

急性呼吸窘迫综合征的分子与免疫生物标志物:肺病理学会成员视角

Molecular and Immune Biomarkers in Acute Respiratory Distress Syndrome: A Perspective From Members of the Pulmonary Pathology Society.
PubMed 文献 · Arch Pathol Lab Med · 2017-06-14

本文从肺病理学会成员视角综述急性呼吸窘迫综合征(ARDS)的发病机制与生物标志物。ARDS以弥漫性肺泡损伤和非心源性水肿为组织学特征,分急性渗出期和纤维增生期,但预测发病和风险分层能力有限。文章讨论临床或实验室可用的生物标志物及其在肺损伤/修复中的生物学作用,并探讨开发验证新检测方法以指导治疗。

要点

  • ARDS组织学特征为弥漫性肺泡损伤和非心源性水肿,分急性渗出期和纤维增生期。
  • 生物标志物可能有助于识别ARDS高危患者、评估治疗反应和预测结局。
  • 文章聚焦生物标志物在肺损伤和修复中的主要生物学作用及新检测方法开发。

核心结论

  • 生物标志物可能有助于识别ARDS高危患者、评估治疗反应、预测结局并改进临床试验。

研究设计与样本

  • 本文为肺病理学会成员视角的综述,检索范围未明确报告。

主要发现

  • ARDS是一种多因素综合征,发病率和死亡率高,以气体交换和肺力学缺陷导致低氧血症、呼吸困难和呼吸衰竭为特征。
  • 组织学上ARDS以急性渗出期(弥漫性肺泡损伤和非心源性水肿)为特征,随后为纤维增生期。
  • 尽管对ARDS发病机制的理解有所增强,但预测ARDS发展和风险分层的能力仍然有限。

临床怎么用

  • 临床或实验室可用的生物标志物可能帮助识别ARDS高危患者、评估治疗反应和预测结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute respiratory distress syndrome (ARDS) is a multifactorial syndrome with high morbidity and mortality rates, characterized by deficiency in gas exchange and lung mechanics that lead to hypoxemia, dyspnea, and respiratory failure. Histologically, ARDS is characterized by an acute, exudative phase, combining diffuse alveolar damage and noncardiogenic edema, followed by a later fibroproliferative phase. Despite an enhanced understanding of ARDS pathogenesis, the capacity to predict the development of ARDS and to risk-stratify patients with the disease remains limited. Biomarkers may help to identify patients at the greatest risk of developing ARDS, to evaluate response to therapy, to predict outcome, and to improve clinical trials. The ARDS pathogenesis is presented in this article, as well as concepts and information on biomarkers that are currently used clinically or are available for laboratory use by academic and practicing pathologists and the developing and validating of new assays, focusing on the assays' major biologic roles in lung injury and/or repair and to ultimately suggest innovative, therapeutic approaches.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Capelozzi VL, Allen TC, Beasley MB, et al. Molecular and Immune Biomarkers in Acute Respiratory Distress Syndrome: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. 2017. PMID: 28613912. doi:10.5858/arpa.2017-0115-SA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。